(Total Views: 420)
Posted On: 07/28/2021 3:48:54 PM
Post# of 30055
Todos Medical Retains CRO for COVID-19 Outpatient and Inpatient Phase 2/3 Clinical Trials for Oral Antiviral 3CL Protease Inhibitor Tollovir
https://newsfilter.io/articles/todos-medical-...b0b344a1dd
https://newsfilter.io/articles/todos-medical-...b0b344a1dd
(1)
(0)Scroll down for more posts ▼
